Skip to main content
The Egyptian Heart Journal

Table 3 Comparison between the studied groups regarding ADMA and endoglin

From: Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension

  

Group I

Group II

Group III

Control group

P value

No = 30

No = 20

No = 18

No = 20

ADMA

Median (IQR)

4.26 (3.99–4.69)

4.14 (3.78–4.48)

4.15 (3.87–4.32)

3.15 (2.8–3.7)a

< 0.001

 

Range

3.2–4.82

3.13–4.78

2.33–4.45

2.06–3.81

 

Endoglin

Median (IQR)

3.75 (2.9–4.6)

1.6 (0.7–2.6)*

2.6 (2.1–3.3)**

0.55 (0.15–1.05)*

< 0.001

 

Range

1.2–8.7

0.1–5.1

1–6

0.1–6.1

 
  1. aHighly significant difference with group 1, 2 and 3 (P < 0.001)
  2. *Highly significant difference with group 1(P < 0.001)
  3. **Significant difference with group 1 (P = 0.011)
Back to article page